Shalata, W.; Gothelf, I.; Dudnik, Y.; Cohen, A.Y.; Abu Jama, A.; Liba, T.; Dan, O.; Tourkey, L.; Shalata, S.; Agbarya, A.;
et al. Correlation Between Body Mass Index and Immunotherapy Response in Advanced NSCLC. Cancers 2025, 17, 1149.
https://doi.org/10.3390/cancers17071149
AMA Style
Shalata W, Gothelf I, Dudnik Y, Cohen AY, Abu Jama A, Liba T, Dan O, Tourkey L, Shalata S, Agbarya A,
et al. Correlation Between Body Mass Index and Immunotherapy Response in Advanced NSCLC. Cancers. 2025; 17(7):1149.
https://doi.org/10.3390/cancers17071149
Chicago/Turabian Style
Shalata, Walid, Itamar Gothelf, Yulia Dudnik, Ahron Yehonatan Cohen, Ashraf Abu Jama, Tom Liba, Ofir Dan, Lena Tourkey, Sondos Shalata, Abed Agbarya,
and et al. 2025. "Correlation Between Body Mass Index and Immunotherapy Response in Advanced NSCLC" Cancers 17, no. 7: 1149.
https://doi.org/10.3390/cancers17071149
APA Style
Shalata, W., Gothelf, I., Dudnik, Y., Cohen, A. Y., Abu Jama, A., Liba, T., Dan, O., Tourkey, L., Shalata, S., Agbarya, A., Meirovitz, A., & Yakobson, A.
(2025). Correlation Between Body Mass Index and Immunotherapy Response in Advanced NSCLC. Cancers, 17(7), 1149.
https://doi.org/10.3390/cancers17071149